Smith & Nephew (NYSE:SNN – Get Rating) was downgraded by research analysts at Canaccord Genuity Group from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday, Marketbeat Ratings reports.
Several other equities analysts have also weighed in on the stock. Barclays reduced their price target on shares of Smith & Nephew from GBX 1,650 ($19.88) to GBX 1,630 ($19.64) in a research report on Tuesday, July 5th. StockNews.com downgraded shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research report on Friday, July 8th. Finally, UBS Group lifted their price target on shares of Smith & Nephew from GBX 1,200 ($14.46) to GBX 1,295 ($15.60) in a report on Friday, April 29th. Four equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $1,455.67.
Smith & Nephew Trading Down 9.8 %
Shares of NYSE:SNN opened at $26.46 on Thursday. Smith & Nephew has a 1 year low of $26.54 and a 1 year high of $44.20. The business has a fifty day moving average price of $29.18 and a two-hundred day moving average price of $31.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.21 and a current ratio of 2.08.
Hedge Funds Weigh In On Smith & Nephew
Smith & Nephew Company Profile
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.
- Get a free copy of the StockNews.com research report on Smith & Nephew (SNN)
- Wingstop And Hershey Are Two Food Stocks Overcoming Inflation
- Can International Business Machines Recover After Its Sell-Off?
- Ford Stock Rallies As EV Strategy Takes Center Stage
- Should High Yield Altria Be In Your Portfolio?
- Is Keurig-Dr. Pepper A Value Worth Buying?
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.